Meeting Coverage
ACG
American College of Gastroenterology
Disease control also maintained with temporary withdrawal, at least initially
Latest ACG Meetings
ECOSPOR IV study found low recurrence regardless of the number of prior episodes
U-ENDURE trial also hit co-primary endpoint for endoscopic response
Ustekinumab, vedolizumab not linked to greater risk of complications
More clinical remissions, endoscopic improvements, early trial finds
Follow-up data from CONFIRM trial show terlipressin benefit in key subgroup
Randomized trial showed improved symptoms at 3 months with gastric electrical stimulation
Intervention "recalibrates the perception of pain in a very powerful manner," researcher explains
Post-hoc analysis suggested less severe disease and longer remission over 1 year
Treatment group achieved clinical remission, met clinical secondary endpoints
Over 50% of patients responding to induction risankizumab maintained clinical remission at 1 year
Assist device was helpful for a particular subgroup of patients
In patients with BMI over 25, nearly 50% reduced use of acid blockers or stopped altogether
Randomized trial revealed one found more and larger adenomas
Study provides support for assessing diabetes markers in pancreatic cyst surveillance